| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 8.834 | 10.325 | 6.202 | 8.086 | 11.153 | 12.130 | 6.031 |
| Total Income - EUR | - | - | - | 8.834 | 10.325 | 6.202 | 8.086 | 11.175 | 12.255 | 6.261 |
| Total Expenses - EUR | - | - | - | 884 | 3.535 | 3.571 | 2.310 | 2.696 | 1.440 | 1.419 |
| Gross Profit/Loss - EUR | - | - | - | 7.949 | 6.790 | 2.632 | 5.776 | 8.479 | 10.815 | 4.843 |
| Net Profit/Loss - EUR | - | - | - | 7.684 | 6.481 | 2.445 | 5.533 | 8.144 | 9.344 | 4.064 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ansial Diagnosis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 816 | 1.058 | 276 | 0 | 0 | 0 |
| Current Assets | - | - | - | 7.916 | 7.141 | 4.731 | 5.507 | 14.255 | 19.507 | 10.933 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 1.054 | 207 | 234 | 1.046 | 237 | 109 |
| Cash | - | - | - | 7.916 | 6.087 | 4.524 | 5.272 | 11.181 | 15.227 | 10.824 |
| Shareholders Funds | - | - | - | 7.727 | 7.736 | 3.833 | 5.643 | 13.804 | 19.063 | 9.753 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 189 | 220 | 1.956 | 140 | 451 | 444 | 1.180 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Ansial Diagnosis Srl